Literature DB >> 20040136

Short communication: Urinary excretion of 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol in a pregnant woman following heavy, chronic cannabis use.

Andreas A Westin1, Marilyn A Huestis, Kjell Aarstad, Olav Spigset.   

Abstract

Differentiating new intake of drugs-of-abuse from residual drug excretion may be difficult, especially following chronic drug usage and for drugs with long elimination half-lives such as cannabis. In the present case, cannabis was found in the urine of a young pregnant woman following heavy and chronic cannabis use. She was warned that if she continued using cannabis while pregnant she would be forced to be hospitalized. She was subjected to serial urine testing with 2-7-day intervals. Urinary 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol (THCCOOH) concentrations, measured by liquid chromatography-mass spectrometry, declined from 348 to 3.9 ng/mL over a surprisingly long period of 12 weeks (84 days). Several algorithms for detecting new drug intake were applied during this time course; most indicated that the woman continued to smoke cannabis following the first urine test. The woman denied any use after the first specimen collection. In retrospect, her THCCOOH excretion profile supports her story. Algorithms for detecting new drug intake have been validated for occasional cannabis users only. We advise caution when interpreting urine test results from heavy, chronic cannabis users, especially when serious consequences are involved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20040136     DOI: 10.1093/jat/33.9.610

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  6 in total

1.  Associations of first trimester co-use of tobacco and Cannabis with prenatal immune response and psychosocial well-being.

Authors:  Kristin Ashford; Amanda Fallin-Bennett; Andrea McCubbin; Amanda Wiggins; Sheila Barnhart; Josh Lile
Journal:  Neurotoxicol Teratol       Date:  2019-03-29       Impact factor: 3.763

2.  Characteristics and quality of life of opioid-dependent pregnant women in Austria.

Authors:  Verena E Metz; Sandra D Comer; Johanna Wuerzl; Anna Pribasnig; Gabriele Fischer
Journal:  Arch Womens Ment Health       Date:  2014-07-15       Impact factor: 3.633

3.  Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence.

Authors:  Randi Melissa Schuster; Kevin Potter; Ryan Vandrey; Maya Hareli; Jodi Gilman; David Schoenfeld; A Eden Evins
Journal:  J Psychopharmacol       Date:  2019-09-19       Impact factor: 4.153

4.  Can physical exercise or food deprivation cause release of fat-stored cannabinoids?

Authors:  Andreas Austgulen Westin; George Mjønes; Ola Burchardt; Ole Martin Fuskevåg; Lars Slørdal
Journal:  Basic Clin Pharmacol Toxicol       Date:  2014-04-22       Impact factor: 4.080

Review 5.  Pharmacokinetics of Cannabis and Its Derivatives in Animals and Humans During Pregnancy and Breastfeeding.

Authors:  Anaëlle Monfort; Ema Ferreira; Grégoire Leclair; Gregory Anton Lodygensky
Journal:  Front Pharmacol       Date:  2022-07-12       Impact factor: 5.988

6.  Screening, quantification, and confirmation of synthetic cannabinoid metabolites in urine by UHPLC-QTOF-MS.

Authors:  Per Ole M Gundersen; Olav Spigset; Martin Josefsson
Journal:  Drug Test Anal       Date:  2018-09-08       Impact factor: 3.345

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.